VITILIGO RESEARCH STUDY

VITILIGO RESEARCH STUDY (58 WEEKS)

Adults from 18 to 75 years of age who have a clinical diagnosis of non-segmental vitiligo, may qualify for this clinical research trial and receive either an investigational injected treatment (active study drug) or placebo.

Eligible participants must have non-segmental vitiligo with disease duration of at least 6 months (defined as the length of time since onset of symptoms), and depigmentation (loss of skin colour) on areas of the face and body (excluding hands and feet).

Participants will have regular visits with an
experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

Individuals will be asked to visit the study centre about 16 times (plus 4 phone visits) over a period of about 58 weeks.

For further information on the study, please follow the link: 

A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) – Full Text View – ClinicalTrials.gov

For more information, please contact:

Principal Investigator
A/Prof Peter Foley                                                                                                                    t: 9623 9431
e: [email protected]

Sub Investigators
Dr Nisal Punchihewa
t: 9623 9464
e: [email protected]

Dr Michelle Rodrigues                                                                                                           e: [email protected]

Study Coordinator
Tracy Mallett
p: 9623 9406
e: [email protected]